Novartis AG (NVS)
NYSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 5.13 | 5.853 | 9.052 | 8.89 | 6.447 | 18.208 | 5.581 | 13.665 |
Return on Equity (%) | 8.831 | 10.331 | 16.494 | 17.479 | 14.386 | 38.592 | 10.932 | 27.981 |
Return on Invested Capital (%) | 19.23 | 16.915 | 27.296 | 15.242 | 26.181 | 35.324 | 16.998 | 25.264 |
Operating Margin (%) | 17.285 | 19.551 | 27.903 | 19.635 | 21.642 | 51.141 | 18.141 | 19.319 |
Net Profit Margin (%) | 13.577 | 15.365 | 23.72 | 23.238 | 16.177 | 45.428 | 13.419 | 27.453 |
Book Value Per Share | 5.156 | 5.24 | 1.97 | 0.103 | -4.37 | 1.759 | -0.697 | -1.646 |
Earnings Per Share | 2.753 | 3.234 | 5.309 | 5.037 | 3.478 | 10.449 | 3.185 | 7.046 |
Cash Per Share | 2.874 | 3.72 | 5.587 | 4.771 | 4.161 | 5.397 | 3.442 | 6.353 |
Working Capital Per Share | 1.116 | 2.018 | 2.508 | 0.532 | -1.459 | 6.747 | 3.78 | 1.941 |
Operating Profit Per Share | 16.368 | 17.231 | 18.178 | 18.511 | 18.523 | 19.608 | 20.303 | 22.631 |
EBIT Per Share | 3.206 | 3.779 | 5.825 | 3.863 | 4.256 | 11.369 | 3.833 | 4.427 |
EBITDA Per Share | 3.206 | 3.779 | 5.825 | 3.863 | 4.256 | 11.369 | 3.833 | 4.427 |
Free Cash Flow Per Share | 4.58 | 5.093 | 7.288 | 6.914 | 5.406 | 12.598 | 5.258 | 8.405 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 2,37B | 2,32B | 2,31B | 2,27B | 2,26B | 2,23B | 2,12B | 2,04B |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 2,12B | 2,1B | 2,07B | 2,06B | 2,04B | N/A | 2,02B | 2B |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 22.782 | N/A | N/A | N/A | 28.32 | N/A | N/A |
Net Profit Margin (%) | N/A | 17.702 | N/A | N/A | N/A | 22.724 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 197,8B |
Ratio cours/bénéfice | 13,03 |
Ratio prix/ventes | 3,58 |
Ratio prix/liquidités | 14,45 |
Ratio prix/valeur comptable | 4,14 |
Rendement de dividende | 339,82% |
Actions en circulation | 2,04B |
Volume moyen (1 semaine) | 1,18M |
Volume moyen (1 mois) | 1,09M |
Variation sur 52 semaines | -1,05% |
Plus haut sur 52 semaines | 120,92 |
Plus bas sur 52 semaines | 92,35 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales